BioSpace News Archive

Arvinas, Inc. announced the appointment of Randy Teel, Ph.D., to the newly created role of Chief Business Officer.

Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the third quarter and nine months ended January 31, 2024.

Shanghai Junshi Biosciences Co., Ltd announced that the Drug Office, Department of Health, the Government of the Hong Kong Special Administrative Region has recently accepted the New Drug Application for toripalimab in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma.